FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2992013302> ?p ?o ?g. }

• W2992013302 endingPage "102" @default.
• W2992013302 startingPage "94" @default.
• W2992013302 abstract "Background and Purpose: Although limited by side effects and development of resistance, doxorubicin still represent the most common chemotherapy for breast cancer. Thus, the identification of critical molecules to alleviate doxorubicin resistance is crucial. Here, we provide a molecular rationale for the breast cancer patients potentially benefitting from doxorubicin based on the expression levels of SIRT1, a identified member of longevity genes. Methods: SIRT1-overexpressed and SIRT1-knockdown breast cancer cells were established to investigate the functions of SIRT1 in regulating doxorubicin resistance both in vitro and in vivo. Cell proliferation was analyzed via CCK8 assay, cell apoptosis was studied by TUNEL anslysis. Molecule interaction was analyzed through co-immunoprecipitation and immunofluorescence techniques. Sensibility to doxorubicin was assessed in vivo through nude mice tumorigenicity experiment. Results:: First, SIRT1 was found higher-expressed in breast cancer doxorubicin-resistant cells MCF-7/ADR than that in doxorubicin- sensitive cells MCF-7. Moreover, SIRT1-knockdown MCF-7/ADR cells showed higher susceptible to doxorubicin both in vitro and in vivo models, whereas overexpressing of SIRT1 obviously inhibited this phenotype. Accordingly, SIRT1 was found interacted with Akt, consequently promoted the activity of Akt in MCF-7/ADR cells in vitro and positively correlated with the expression of P-Akt in vivo. Reversion the activity of Akt partially downturned the doxorubicin-resistant effects mediated by SIRT1. Conclusion: This investigation suggested the value of SIRT1 as biomarker of response to doxorubicin, leading to the development of new tools for the management of breast cancer patients." @default.
• W2992013302 created "2019-12-13" @default.
• W2992013302 creator A5001580073 @default.
• W2992013302 creator A5004780683 @default.
• W2992013302 creator A5015617851 @default.
• W2992013302 creator A5018204703 @default.
• W2992013302 creator A5020254575 @default.
• W2992013302 creator A5034618391 @default.
• W2992013302 creator A5049842580 @default.
• W2992013302 creator A5085824200 @default.
• W2992013302 date "2020-04-10" @default.
• W2992013302 modified "2023-10-06" @default.
• W2992013302 title "High Expression of SIRT1 Associates with the Doxorubicin Resistance of Breast Cancer through the Activation of Akt" @default.
• W2992013302 cites W1951075546 @default.
• W2992013302 cites W1994704630 @default.
• W2992013302 cites W2034591470 @default.
• W2992013302 cites W2037723157 @default.
• W2992013302 cites W2037731733 @default.
• W2992013302 cites W2043661576 @default.
• W2992013302 cites W2047117413 @default.
• W2992013302 cites W2059755711 @default.
• W2992013302 cites W2065547075 @default.
• W2992013302 cites W2072475608 @default.
• W2992013302 cites W2089605820 @default.
• W2992013302 cites W2096161049 @default.
• W2992013302 cites W2098494491 @default.
• W2992013302 cites W2105537982 @default.
• W2992013302 cites W2141176449 @default.
• W2992013302 cites W2148931486 @default.
• W2992013302 cites W2158742352 @default.
• W2992013302 cites W2169601017 @default.
• W2992013302 cites W2548705349 @default.
• W2992013302 cites W2586263334 @default.
• W2992013302 cites W2605803944 @default.
• W2992013302 cites W2732717343 @default.
• W2992013302 cites W2755778068 @default.
• W2992013302 cites W2762285338 @default.
• W2992013302 cites W2762481118 @default.
• W2992013302 cites W2768492615 @default.
• W2992013302 cites W2804392847 @default.
• W2992013302 cites W4240326356 @default.
• W2992013302 doi "https://doi.org/10.2174/1871520619666191028100405" @default.
• W2992013302 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31746308" @default.
• W2992013302 hasPublicationYear "2020" @default.
• W2992013302 type Work @default.
• W2992013302 sameAs 2992013302 @default.
• W2992013302 citedByCount "5" @default.
• W2992013302 countsByYear W29920133022019 @default.
• W2992013302 countsByYear W29920133022020 @default.
• W2992013302 countsByYear W29920133022022 @default.
• W2992013302 countsByYear W29920133022023 @default.
• W2992013302 crossrefType "journal-article" @default.
• W2992013302 hasAuthorship W2992013302A5001580073 @default.
• W2992013302 hasAuthorship W2992013302A5004780683 @default.
• W2992013302 hasAuthorship W2992013302A5015617851 @default.
• W2992013302 hasAuthorship W2992013302A5018204703 @default.
• W2992013302 hasAuthorship W2992013302A5020254575 @default.
• W2992013302 hasAuthorship W2992013302A5034618391 @default.
• W2992013302 hasAuthorship W2992013302A5049842580 @default.
• W2992013302 hasAuthorship W2992013302A5085824200 @default.
• W2992013302 hasConcept C109541995 @default.
• W2992013302 hasConcept C121608353 @default.
• W2992013302 hasConcept C126322002 @default.
• W2992013302 hasConcept C173396325 @default.
• W2992013302 hasConcept C185592680 @default.
• W2992013302 hasConcept C190283241 @default.
• W2992013302 hasConcept C207001950 @default.
• W2992013302 hasConcept C2776694085 @default.
• W2992013302 hasConcept C2781303535 @default.
• W2992013302 hasConcept C2994423619 @default.
• W2992013302 hasConcept C502942594 @default.
• W2992013302 hasConcept C530470458 @default.
• W2992013302 hasConcept C54355233 @default.
• W2992013302 hasConcept C55493867 @default.
• W2992013302 hasConcept C71924100 @default.
• W2992013302 hasConcept C75217442 @default.
• W2992013302 hasConcept C86803240 @default.
• W2992013302 hasConcept C96232424 @default.
• W2992013302 hasConceptScore W2992013302C109541995 @default.
• W2992013302 hasConceptScore W2992013302C121608353 @default.
• W2992013302 hasConceptScore W2992013302C126322002 @default.
• W2992013302 hasConceptScore W2992013302C173396325 @default.
• W2992013302 hasConceptScore W2992013302C185592680 @default.
• W2992013302 hasConceptScore W2992013302C190283241 @default.
• W2992013302 hasConceptScore W2992013302C207001950 @default.
• W2992013302 hasConceptScore W2992013302C2776694085 @default.
• W2992013302 hasConceptScore W2992013302C2781303535 @default.
• W2992013302 hasConceptScore W2992013302C2994423619 @default.
• W2992013302 hasConceptScore W2992013302C502942594 @default.
• W2992013302 hasConceptScore W2992013302C530470458 @default.
• W2992013302 hasConceptScore W2992013302C54355233 @default.
• W2992013302 hasConceptScore W2992013302C55493867 @default.
• W2992013302 hasConceptScore W2992013302C71924100 @default.
• W2992013302 hasConceptScore W2992013302C75217442 @default.
• W2992013302 hasConceptScore W2992013302C86803240 @default.
• W2992013302 hasConceptScore W2992013302C96232424 @default.
• W2992013302 hasFunder F4320321001 @default.
• W2992013302 hasIssue "1" @default.

• next